However, in the present study the correlations found for CDH1 and RASSF1A in pRCC are the in opposite direction of those described in prostate carcinomas, as higher CDH1 and RASSF1A methylation levels were associated with lower renal tumor stage and grade, respectively. The gene discussed is RASSF1; the disease is kidney neoplasm.